Alleyesonme, thank you very much for that informative post!The land sale and Hexo settlement then will add ~ $11 million in cash to the balance sheet. More than enough imho until they hit profitability. Pidduck's reply was spot on w.r.t. to shares....the shares only gain value as the big picture generates profits/+EPS.
I was enjoying a coffee with Athea this morning when the 'FDA drug monograph' comment came to mind again. Imho, that was Pidduck telling investors....the best way he could, nows the time to start accumulating more if you need to because after drug monograph the company can proceed with sales for that new drug and even other API's.
Drug Monograph = time to load up
Keep in mind, they have over 19 other products in 'strong' late stage clinical trial and we don't know how close those are to being commercialized as well. This is very IMPORTANT imho. Some of those clinical trials may not be for cannabinoid based new drugs as evidenced by their ANDA submission to the FDA. Some of those clinical trials could include, as a very strong example, traditional antibiotics combined with cannabinoid API's....a hybrid of the original drug = ANDA!!!